OAT3 Antibodies

Santa Cruz Biotechnology delivers a wide array of OAT3 monoclonal antibodies for investigating organic anion transporter 3 (OAT3) in biological processes. Multiple experimental applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). OAT3 plays a crucial role in renal excretion of organic anions, significantly impacting drug metabolism and clearance. The function of OAT3 is essential for maintaining homeostasis and influencing pharmacokinetics, making it a key focus in drug interaction and toxicology studies. Research focused on OAT3 expression and regulation continues to advance understanding of various diseases and potential therapeutic approaches. Investigating OAT3 function has revealed important insights about kidney function and drug transport mechanisms. Current research directions include exploring OAT3's role in drug-drug interactions and developing targeted therapies. Understanding OAT3 regulation has significant implications for improving drug development and personalized medicine approaches. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of OAT3 and its impact on human health.